+1-518-621-2074 | US-Canada Toll Free Contact Us

Increase in Prevalence of Allergic Rhinitis and New Treatment Discoveries to Boost Growth Rate of Allergic Rhinitis Market

about us

Published on : Feb 26, 2021

The allergic rhinitis market is observing an upward trend and is predicted to continue with the same growth rate. Allergic rhinitis is caused due to specific allergens. Also known as pollinosis or hay fever, allergic rhinitis occurs when the immune system overreacts with allergens in conducive conditions. Allergic rhinitis is commonly caused due to pollen. Dust, mold, and animal dander can also cause allergic rhinitis. Symptoms include sneezing, itching nose, and stuffy nose.  

This allergy can be diagnosed with the help of nasal passage analysis of the suspected patient, while skin testing is also an efficient testing method. On the basis of drug class, the in the allergic rhinitis market is classified into antihistamines, immunotherapies, and intranasal corticosteroids. 

This report on the allergic rhinitis market analyzes prominent factors influencing the growth rate of the allergic rhinitis market. The research report includes path-breaking research by experts in this field and also includes the present condition of the allergic rhinitis market and future prospects as well.   

Weakened immunity levels are on the rise due to lack of exercise and overconsumption of hazardous food items such as junk food. This may contribute to the growth of the allergic rhinitis market. In addition, growing awareness about allergic rhinitis treatment will further boost the allergic rhinitis market. Tobacco consumption is also one of the main causes of allergic rhinitis. As the consumption of tobacco consumption is on the rise around the globe, it may benefit the allergic rhinitis market greatly. 

The allergic rhinitis market is highly fragmented and comprises of many competitors battling for the dominant position. Manufacturers in the allergic rhinitis market are currently focusing on research and development activities to find efficient drugs that can treat rhinitis quickly. Many innovative treatments are considerably increasing that may accelerate the growth rate of the allergic rhinitis market. 

Antihistamines are widely applied as a prominent treatment method for relieving or preventing allergic rhinitis. Therefore, numerous companies are investing heavily in intranasal antihistamines development. This may bring about a paradigm shift in the growth of the allergic rhinitis market. Key players of the allergic rhinitis market are Meda Pharmaceuticals, Merck, Sanofi, Johnson&Johnson, AstraZeneca, ALK-Abell, and Teva. 

Over-the-counter medicines are also on the rise as many patients with mild symptoms prefer to self-medicate rather than visiting a doctor. In addition, over-the-counter medicines do not require prescriptions and are easily available across any medical store. Hence, this may benefit the allergic rhinitis market to a great extent and help in multiplying the growth rate. 

There are many types of research being conducted to find more effective ways of curing allergic rhinitis. For instance, recently researchers have found that nitric oxide (NO) is a beneficial tool for patient follow-up with persistent allergic rhinitis and assists medical practitioners to measure the treatment response level. In addition, many new methods are cropping up that promise speedy recovery from allergic rhinitis. Posterior Nasal Nerve Neurectomy is one of the options. This is an efficient method for removing pathological neural networks that cause unregulated nasal hypersensitivity in patients with severe allergic rhinitis. 

Get Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2621307

The allergic rhinitis market is regionally spread across North America, Middle East and Africa, South America, Asia Pacific, and Europe. North America may record a dominating streak due to a considerable number of allergic rhinitis cases in the U.S.A. The prevalence of suitable infrastructure and the availability of a varied range of drugs in the region prove to be a breeding ground for the growth of the allergic rhinitis market. The Asia Pacific region is also predicted to observe steady growth due to growing awareness among the individuals in this region about allergic rhinitis.